samedan logo

home > news > detailed info

Virisure & Bionique Join Forces

ViruSure GmbH

VIENNA, AUSTRIA – 15th December 2021 – Asahi Kasei Medical Co., Ltd (Asahi Kasei Medical) announced today the acquisition of Bionique Testing Laboratories LLC, a US-based leader in mycoplasma testing services for the biologics and life-sciences industries. Bionique joins ViruSure GmbH as part of the global biosafety testing services unit of Asahi Kasei Medical’s Bioprocess Division. Both Bionique and ViruSure will continue operations under their existing, widely respected brands.

The acquisition brings together the unique mycoplasma and viral safety proficiencies of ViruSure and Bionique, enabling Asahi Kasei Medical to offer clients expansive and exceptionally reliable biosafety testing support that is based on industry-leading scientific expertise, and is delivered via customized, trustworthy project partnerships. Asahi Kasei Medical is also actively investing in the Bionique facilities in Saranac Lake, NY, USA and employment expansion at the operating sites of both Bionique and ViruSure, to meet increasing demand for its testing services.

“We are excited to have a strategic partner like Bionique as part of the Asahi Kasei Group, and the expertise in mycoplasma testing that they bring will further strengthen our goal to better service our customers in all areas of biosafety testing” said Andy Bailey, CEO of ViruSure.
phone +43 (0)1 269 91 20
email Tech Gate Vienna, Wissenschafts- und Technologiepark, Bauteil Gate Ebene -2, Donau-City-Straße 1, A-1220 Vienna
Print this page
Send to a friend
News and Press Releases

ACG appoints Udit K Singh as CEO of ACG Inspection

Mumbai 26 April, 2022: ACG, a leading supplier of fully integrated manufacturing solutions to the global pharmaceutical and nutraceutical industry, is pleased to announce the appointment of Mr. Udit K Singh as the new chief executive officer (CEO) of its Inspection Division.
More info >>

White Papers

Smaller, Smarter, Electronic, Connected: The Next Generation of Drug-Delivery Devices


An exciting trend in drug delivery is underway: the movement toward smaller, smarter, wirelessly connected electronic devices that allow patient-administered therapy. Inspired by the technological advancements driving the consumer electronics market, new methods for drug delivery show great promise for all stakeholders. Patients wishing to claim more autonomy over their drug regimens, caregivers and medical professionals wanting to more closely monitor drug compliance, health insurance organizations looking to keep costs down, and developers of pharmaceutical products interested in conducting better managed clinical trials can all benefit from these novel, next-generation technologies.
More info >>

Industry Events

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022)

20-21 June 2022, Berlin, Germany

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) is held on June, 20-21, 2022 in Berlin, Germany. The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies to discuss the manufacturing and packaging processes of the pharmaceutical industry. Among the participating companies are Bayer, Sandoz, Merck, Novartis, Roche, Genveon, Samsung Biologics, Pfizer.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement